Skip to main content

Table 5 Rank-Sum Test of Antibody Fold Change

From: Factors affecting the immunogenicity of influenza vaccines in human

Variable

Category

A/H1N1

A/H3N2

B/Victoria

B/Yamagata

M(P25,P75)

P

M(P25,P75)

P

M(P25,P75)

P

M(P25,P75)

P

Gender

Male

1.86(1.00-2.72)

0.18

1.43(1.16–1.90)

0.33

1.63(1.00-2.72)

0.03

1.32(1.00-1.75)

0.21

 

Female

1.88(1.16–3.15)

1.62(1.16–2.20)

2.29(1.12–2.74)

1.38(1.00-2.39)

Age Group

≤ 5

1.27(1.00-2.14)

< 0.001

1.56(1.19–1.94)

0.68

1.39(1.00-2.72)

0.003

1.00(0.80–1.72)

0.04

 

6–17

1.94(1.28–2.42)

1.37(1.00-1.90)

2.11(1.00-2.74)

1.29(1.10–1.79)

 

18–64

2.34(1.27–3.26)

1.69(1.23–2.20)

2.29(1.19–3.15)

1.60(1.19–2.72)

 

≥ 65

1.86(1.00-3.15)

1.30(1.00-1.86)

1.65(1.00-2.72)

1.17(1.00-1.82)

Frequency of Colds

≤ 1

2.29(1.16–3.15)

0.3

1.00(1.00-1.54)

< 0.001

1.86(1.00-2.72)

0.58

1.38(1.00-1.69)

0.09

 

2–3

1.86(1.14–3.15)

1.47(1.19–1.94)

1.94(1.12–2.72)

1.56(1.00-2.39)

 

4–6

1.47(1.07–2.72)

1.94(1.47–2.74)

1.47(1.00-2.94)

1.00(0.69–1.28)

 

>6

2.12(1.50–3.48)

1.86(1.22–3.37)

1.71(1.20–3.05)

1.43(0.86–2.47)

Vaccination History

No

2.16(1.14–3.15)

< 0.001

1.56(1.18–2.20)

0.20

2.29(1.00-3.15)

< 0.001

1.69(1.00-2.51)

0.005

 

Yes

1.38(1.09–2.29)

1.43(1.09–1.90)

1.29(1.00-2.29)

1.19(1.00-1.41)

Chronic Diseases

No

2.25(1.14–3.15)

0.20

1.60(1.19–2.20)

0.98

1.94(1.16–2.74)

0.02

1.49(1.05–2.67)

0.34

 

Yes

1.86(1.16–3.05)

1.53(1.23–2.36)

1.63(1.14–2.67)

1.31(1.00-2.02)

  1. M: median; P25: lower quartile; P75: upper quartile